Načítá se...
Understanding patient preferences and willingness to pay for hemophilia therapies
BACKGROUND: Despite clearly improved clinical outcomes for prophylaxis compared to on-demand therapy, on average only 56% of patients diagnosed with severe hemophilia receive prophylactic factor replacement therapy in the US. Prophylaxis rates generally drop as patients transition from childhood to...
Uloženo v:
| Vydáno v: | Patient Prefer Adherence |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4646600/ https://ncbi.nlm.nih.gov/pubmed/26635471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S92985 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|